Phillips Gary M.
SEC-identified person · CIK 1197795 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aldeyra Therapeutics, Inc. ALDX | Director | filed 2014–2026 |
| Zyla Life Sciences ZCOR | Director | filed 2019–2020 |
| Mallinckrodt plc MNKTQ | Sr. VP, Chief Strategy Officer | filed 2013–2018 |
| Rocket Pharmaceuticals, INC. RCKT | Director | filed 2015–2017 |
| Bausch & Lomb INC BOL | Vice President | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.